HAP Trading’s Seres Therapeutics MCRB Stock Holding History

HAP Trading’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,630	Closed	-$33K	–	2570
2021 Q4	$33K	Buy	+1,630	New	+$259K	﹤0.01%	1643

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

HAP Trading's MCRB Position: Q4 2021 in Review

HAP Trading sold out of Seres Therapeutics (MCRB) in Q4 2021, closing a stake of 2,002 shares — an estimated $318K sold.

HAP Trading first reported a position in MCRB in Q3 2021 and held it in 1 quarter. The position peaked at $279K in Q3 2021. 148 funds tracked by Wall St. Rank hold MCRB as of Q4 2021.

HAP Trading reported no remaining Seres Therapeutics position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 2,002 Seres Therapeutics shares in Q4 2021, an estimated $318K.
HAP Trading first reported a position in Seres Therapeutics in Q3 2021 and held it in 1 quarter.
HAP Trading's Seres Therapeutics position peaked at $279K in Q3 2021.
148 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.